
15/08/2025
๐ BaciNebusal โ Breakthrough Probiotic Nasal Spray for Respiratory Health
CPC1 Hanoi Pharmaceutical JSC proudly presents BaciNebusal, the innovative 4-in-1 nasal spray that combines probiotics, prebiotics, hypertonic saline, and hyaluronate โ delivering a powerful, non-antibiotic solution for sinusitis and upper respiratory care.
๐น Key Benefits for the Market
Probiotic Therapy: Bacillus clausii & Bacillus subtilis inhibit harmful bacteria, protect nasal mucosa, and support IgA antibody production.
**MAD Nasal: Fine particle delivery (30โ100 ฮผm) ensures probiotics reach deep into the sinuses for maximum effect.
**Moisturizing & Protection: Sodium hyaluronate deeply hydrates, while hypertonic saline reduces swelling, clears mucus, and eases breathing.
**Safe & Versatile: Suitable for infants, children, pregnant & lactating women; can be used alongside antibiotics.
๐ Why Importers & Distributors Choose BaciNebusal
**Market Potential: Upper respiratory tract infection treatment market projected at USD 82.8B by 2033, growing 8% annually.
**Competitive Advantage: Higher probiotic dose, single-dose hygiene, deep moisturizing, and local targeted effect โ outperforming many market products.
**Non-Antibiotic Revolution: Reduces antibiotic resistance risks, safe for long-term use, ideal for chronic sinusitis management.
๐ Distribution Opportunity
Bring a scientifically proven, technology-driven, and highly differentiated respiratory health product to your market.
๐ฉ For business inquiries or product consultation:
โ Email: Thanhxuan.exp@cpc1hn.vn
๐ Whatsapp: +84.984.404.650
๐ Website: https://cpc1hn.com/